The store will not work correctly when cookies are disabled.
3-(2-Phenylimidazo[1,2-a]pyridin-6-yl)benzonitrile
ID: ALA4566360
PubChem CID: 155561101
Max Phase: Preclinical
Molecular Formula: C20H13N3
Molecular Weight: 295.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1cccc(-c2ccc3nc(-c4ccccc4)cn3c2)c1
Standard InChI: InChI=1S/C20H13N3/c21-12-15-5-4-8-17(11-15)18-9-10-20-22-19(14-23(20)13-18)16-6-2-1-3-7-16/h1-11,13-14H
Standard InChI Key: ZIPMVBBAKJZVIG-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
30.0242 -7.8376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0230 -8.6571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7311 -9.0661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4407 -8.6566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4379 -7.8340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7293 -7.4287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1456 -9.0634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1455 -9.8817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8530 -10.2891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8491 -8.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5572 -9.0579 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.5642 -9.8764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3448 -10.1227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.8203 -9.4564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3335 -8.7984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6361 -9.4476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0502 -10.1534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8666 -10.1468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2699 -9.4350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8509 -8.7285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0358 -8.7387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3153 -9.0672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6072 -9.4752 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 12 1 0
11 10 1 0
10 7 2 0
4 7 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 11 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
14 16 1 0
22 23 3 0
2 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 295.35 | Molecular Weight (Monoisotopic): 295.1109 | AlogP: 4.54 | #Rotatable Bonds: 2 |
Polar Surface Area: 41.09 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.39 | CX LogP: 4.30 | CX LogD: 4.29 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.54 | Np Likeness Score: -1.79 |
References
1. Quattrini L, Gelardi ELM, Coviello V, Sartini S, Ferraris DM, Mori M, Nakano I, Garavaglia S, La Motta C.. (2020) Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells., 63 (9): [PMID:32223240] [10.1021/acs.jmedchem.9b01910] |